Tirzepatide

About Tirzepatide

Tirzepatide is a novel synthetic peptide that functions as a dual GIP/GLP-1 receptor agonist, representing a unique class of incretin mimetics in metabolic research. This dual-agonist approach is extensively studied in laboratories investigating synergistic effects of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) pathway activation.

Key Research Applications

Dual Incretin Pathway Research: Tirzepatide is utilized to study the combined effects of GIP and GLP-1 receptor activation on insulin secretion, glucagon regulation, and glucose homeostasis in cellular and tissue models.

Metabolic Syndrome Studies: Research laboratories employ Tirzepatide to investigate mechanisms of body weight regulation, energy expenditure, lipid metabolism, and insulin sensitivity in metabolic research protocols.

Beta Cell Preservation: The peptide is used in pancreatic research to study protective effects on beta cell mass, insulin biosynthesis capacity, and glucose-stimulated insulin secretion mechanisms.

Hepatic Metabolism: Tirzepatide research includes investigating effects on hepatic glucose production, glycogen synthesis, lipogenesis pathways, and NAFLD-related mechanisms in laboratory settings.

Mechanism of Action (Research Context)

In research models, Tirzepatide demonstrates high affinity for both GIP and GLP-1 receptors with modifications that provide extended half-life characteristics. The dual agonism activates both incretin pathways simultaneously, potentially offering synergistic benefits in glucose regulation and metabolic pathway modulation studied in laboratory research.

Product Specifications

Form: Lyophilized sterile powder requiring reconstitution with bacteriostatic water for research use.

Purity: Supplied at ≥98% purity (HPLC verified) for laboratory research applications.

Storage: Store lyophilized powder at -20°C protected from light. After reconstitution, store at 2-8°C and use within manufacturer-specified timeframe.

Important: Tirzepatide is strictly for in-vitro laboratory research only. NOT for human consumption, clinical use, or in-vivo application outside approved research protocols.